Anika Therapeutics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Anika Therapeutics (ANIK)
Anika Therapeutics: Strong Q4 Performance and Upbeat FY2024 Outlook Justify Buy Rating and Raised Price Target
Anika Therapeutics Analyst Ratings
Barrington Research Maintains Outperform on Anika Therapeutics, Raises Price Target to $29
Anika Therapeutics Analyst Ratings
Anika Therapeutics Receives Buy Rating Based on Strong Q3 Performance and Positive 2023 Outlook
Anika Therapeutics (ANIK) Receives a Buy From Barrington
Barrington Research Upgrades Anika Therapeutics to Outperform, Announces $24 Price Target
Anika Therapeutics Analyst Ratings
Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23
Anika Therapeutics Analyst Ratings
Analysts' Top Healthcare Picks: Anika Therapeutics (ANIK), Outset Medical (OM)
Stephens & Co. Reiterates Equal-Weight on Anika Therapeutics, Maintains $28 Price Target
Barrington Keeps Their Hold Rating on Anika Therapeutics (ANIK)
Stephens Sticks to Its Hold Rating for Anika Therapeutics (ANIK)
Stephens & Co. Reiterates Equal-Weight on Anika Therapeutics, Maintains $28 Price Target
Anika Therapeutics (ANIK) Was Downgraded to a Hold Rating at Barrington
Anika Therapeutics Analyst Ratings
Barrington Research Upgrades Anika Therapeutics to Outperform, Announces $31 Price Target
No Data